$85,000,000 SENIOR SUBORDINATED NOTE PURCHASE AGREEMENT Datedas of September 30, 2010 among CBAY INC., MEDQUIST INC., and MEDQUIST TRANSCRIPTIONS, LTD, AS ISSUERS, CBAYSYSTEMS HOLDINGS LIMITED, AS HOLDINGS and BLACKROCK KELSO CAPITAL CORPORATION, PENNANTPARK INVESTMENT CORPORATION CITIBANK, N.A. and THL CREDIT, INC. AS PURCHASERS f f f

EX-10.2 3 w80006exv10w2.htm EX-10.2 exv10w2
EXHIBIT 10.2
EXECUTION VERSION
$85,000,000
SENIOR SUBORDINATED NOTE PURCHASE AGREEMENT
Dated as of September 30, 2010
among
CBAY INC., MEDQUIST INC.,
and
MEDQUIST TRANSCRIPTIONS, LTD,
AS ISSUERS,
CBAYSYSTEMS HOLDINGS LIMITED, AS HOLDINGS
and
BLACKROCK KELSO CAPITAL CORPORATION,
PENNANTPARK INVESTMENT CORPORATION
CITIBANK, N.A.
and
THL CREDIT, INC.
AS PURCHASERS

 


 

This Agreement and the rights and obligations evidenced hereby are subordinate in the manner and to the extent set forth in that certain Subordination and Intercreditor Agreement (the “Subordination Agreement”) among Blackrock Kelso Capital Corporation (“BKC”), PennanPark Investment Corporation (“Pennant”), Citibank, N.A. (“Citibank”), THL Credit, Inc. (“THL” and together with BKC, Pennat and Citibank, the “Purchasers”), CBay Inc., a Delaware corporation (“CBay”), MedQuist Inc., a New Jersey corporation (“MedQuist”), MedQuist Transcriptions, Ltd., a New Jersey corporation (“MedQuist Transcriptions”, and together with CBay and MedQuist, the “Issuers”) and General Electric Capital Corporation (“Agent”), to the indebtedness (including interest) owed by the Companies pursuant to that certain Credit Agreement dated as of October 1, 2010 among the Companies, Agent and the lenders from time to time party thereto, as such Credit Agreement has been and hereafter may be amended, supplemented or otherwise modified from time to time and to indebtedness refinancing the indebtedness under that agreement as contemplated by the Subordination Agreement; and each holder of this instrument, by its acceptance hereof, irrevocably agrees to be bound by the provisions of the Subordination Agreement.

2


 

TABLE OF CONTENTS
         
ARTICLE 1 DEFINITIONS, INTERPRETATION AND ACCOUNTING TERMS
    7  
 
       
Section 1.1 Defined Terms
    7  
Section 1.2 UCC Terms
    36  
Section 1.3 Accounting Terms and Principles
    36  
Section 1.4 Pro Forma
    36  
Section 1.5 Payments
    36  
Section 1.6 Interpretation
    37  
 
       
ARTICLE 2 ISSUANCE AND SALE OF NOTES; INTEREST AND REPAYMENT
    37  
 
       
Section 2.1 Note Issuance
    37  
Section 2.2 Procedures for Issuance
    38  
Section 2.3 [Reserved.]
    38  
Section 2.4 [Reserved.]
    38  
Section 2.5 [Reserved.]
    38  
Section 2.6 Repayment and Prepayment of Obligations
    38  
Section 2.7 Interest
    40  
Section 2.8 AHYDO Payments
    41  
Section 2.9 [Reserved.]
    41  
Section 2.10 Application of Payments
    41  
Section 2.11 Payments and Computations
    42  
Section 2.12 Evidence of Debt
    42  
Section 2.13 [Reserved.]
    43  
Section 2.14 [Reserved.]
    43  
Section 2.15 [Reserved.]
    43  
Section 2.16 [Reserved.]
    43  
Section 2.17 Taxes
    43  
Section 2.18 [Reserved.]
    46  
Section 2.19 Issuer Representative
    46  
 
       
ARTICLE 3 CONDITIONS TO PURCHASE OF NOTES
    47  
 
       
Section 3.1 Conditions Precedent to Purchase of Notes
    47  
Section 3.2 Conditions to Funding
    49  
 
       
ARTICLE 4 REPRESENTATIONS AND WARRANTIES
    49  
 
       
Section 4.1 Corporate Existence; Compliance with LAw
    49  
Section 4.2 Note Documents and Related Documents
    50  
Section 4.3 Ownership of Group Members
    50  
Section 4.4 Financial Statements
    51  
Section 4.5 Material Adverse Effect
    51  
Section 4.6 Solvency
    52  
Section 4.7 Litigation
    52  
Section 4.8 Taxes
    52  
Section 4.9 Margin Regulations
    52  
Section 4.10 No Defaults
    52  
Section 4.11 Investment Company Act
    52  
Section 4.12 Labor Matters
    53  
Section 4.13 ERISA
    53  
Section 4.14 Environmental Matters
    53  
Section 4.15 Intellectual Property
    54  
Section 4.16 Title; Real Property
    54  
Section 4.17 Full Disclosure
    54  

 


 

         
Section 4.18 Anti-Terrorism Laws
    55  
Section 4.19 Material Agreement
    55  
Section 4.20 Health Care Matters
    55  
Section 4.21 Health Care Permits
    55  
Section 4.22 Exclusion
    55  
Section 4.23 HIPAA
    56  
 
       
ARTICLE 5 FINANCIAL COVENANTS
    56  
 
       
Section 5.1 Maximum Consolidated Senior Leverage Ratio
    56  
Section 5.2 Maximum Consolidated Total Leverage Ratio
    57  
Section 5.3 [Reserved.]
    58  
Section 5.4 Minimum Consolidated Interest Coverage Ratio
    58  
 
       
ARTICLE 6 REPORTING COVENANTS
    58  
 
       
Section 6.1 Financial Statements
    58  
Section 6.2 Other Events
    60  
Section 6.3 Copies of Notices and Reports
    61  
Section 6.4 Labor Matters
    61  
Section 6.5 ERISA-Related Information
    61  
 
       
ARTICLE 7 AFFIRMATIVE COVENANTS
    62  
 
       
Section 7.1 Maintenance of Corporate
    62  
Section 7.2 Compliance with Laws, Etc.
    62  
Section 7.3 Payment of Obligations
    62  
Section 7.4 Maintenance of Property
    62  
Section 7.5 Maintenance of Insurance
    63  
Section 7.6 Keeping of Books
    63  
Section 7.7 Access to Books and Property
    63  
Section 7.8 Environmental
    64  
Section 7.9 Use of Proceeds
    64  
Section 7.10 Additional Guaranties
    64  
Section 7.11 [Reserved.]
    64  
Section 7.12 Compliance Program
    64  
 
       
ARTICLE 8 NEGATIVE COVENANTS
    65  
 
       
Section 8.1 Indebtedness
    65  
Section 8.2 Liens
    67  
Section 8.3 Investments
    68  
Section 8.4 Asset Sales
    69  
Section 8.5 Restricted Payments
    71  
Section 8.6 Prepayment of Indebtedness
    73  
Section 8.7 Fundamental Changes
    73  
Section 8.8 Change in Nature of Business
    74  
Section 8.9 Transactions with Affiliates
    74  
Section 8.10 Third-Party Restrictions on Indebtedness, Liens, Investments or Restricted Payments
    76  
Section 8.11 Modification of Certain Documents
    77  
Section 8.12 Fiscal Year
    77  
Section 8.13 Margin Regulations
    77  
Section 8.14 Compliance with ERISA
    77  
Section 8.15 Hazardous Materials
    77  
Section 8.16 Limitation on Layering Indebtedness
    77  
 
       
ARTICLE 9 EVENTS OF DEFAULT
    78  

4


 

         
Section 9.1 Definition
    78  
Section 9.2 Remedies
    80  
 
       
ARTICLE 10 RESERVED
    80  
 
       
ARTICLE 11 MISCELLANEOUS
    80  
 
       
Section 11.1 Amendments, Waivers, Etc.
    80  
Section 11.2 Assignments and Participations; Binding Effect
    81  
Section 11.3 Costs and Expenses
    83  
Section 11.4 Indemnities
    83  
Section 11.5 Survival
    84  
Section 11.6 Limitation of Liability for Certain Damages
    84  
Section 11.7 Noteholder-Issuer Relationship
    85  
Section 11.8 [Reserved.]
    85  
Section 11.9 Sharing of Payments, Etc.
    85  
Section 11.10 [Reserved.]
    85  
Section 11.11 Addresses
    85  
Section 11.12 Electronic Transmissions
    86  
Section 11.13 Governing Law
    87  
Section 11.14 Jurisdiction
    87  
Section 11.15 Waiver of Jury Trial
    88  
Section 11.16 Severability
    88  
Section 11.17 Execution in Counterparts
    88  
Section 11.18 Entire Agreement
    88  
Section 11.19 Use of Name
    88  
Section 11.20 Non-Public Information; Confidentiality
    88  
Section 11.21 Patriot Act Notice
    89  
 
       
ARTICLE 12 CROSS-GUARANTY
    89  
 
       
Section 12.1 Cross-Guaranty
    89  
Section 12.2 Waivers by Issuers
    90  
Section 12.3 Benefit of Guaranty
    90  
Section 12.4 Subordination of Subrogation, Etc.
    90  
Section 12.5 Election of Remedies
    91  
Section 12.6 Limitation
    91  
Section 12.7 Contribution with Respect to Guaranty Obligations
    91  
Section 12.8 Liability Cumulative
    92  
Section 12.9 Subordination
    92  

5


 

SCHEDULES
     
Schedule I
  Commitments
Schedule II
  Addresses for Notices
Schedule 4.3
  Capitalization
Schedule 4.12
  Labor Matters
Schedule 4.14
  Environmental Matters
Schedule 4.19
  Material Agreements
Schedule 4.21
  Health Care Permits
Schedule 8.1
  Indebtedness
Schedule 8.2
  Liens
Schedule 8.3
  Investments
Schedule 8.9
  Affiliate Transactions
Schedule 8.10
  Contractual Obligations
EXHIBITS
     
Exhibit A
  Form of Assignment Agreement
Exhibit B
  Form of Note
Exhibit C
  PIK Toggle Notice
Exhibit D
  Form of Compliance Certificate
Exhibit E
  Subordination Agreement

6


 

          THIS SENIOR SUBORDINATED NOTE PURCHASE AGREEMENT, DATED AS OF SEPTEMBER 30, 2010, IS ENTERED INTO AMONG CBAY INC., A DELAWARE CORPORATION (“CBAY”), MEDQUIST INC., A NEW JERSEY CORPORATION (“MEDQUIST”), MEDQUIST TRANSCRIPTIONS, LTD., A NEW JERSEY CORPORATION (“MEDQUIST TRANSCRIPTIONS”, AND TOGETHER WITH CBAY AND MEDQUIST, THE “ISSUERS”), CBAYSYSTEMS HOLDINGS LIMITED, A COMPANY INCORPORATED IN THE BRITISH VIRGIN ISLANDS AND AS SUCH ENTITY MAY BE CONVERTED TO A DELAWARE CORPORATION PURSUANT TO SECTION 265 OF THE DELAWARE GENERAL CORPORATION LAW (“HOLDINGS”), MEDQUIST, AS ISSUER REPRESENTATIVE, BLACKROCK KELSO CAPITAL CORPORATION (“BKC”), PENNANTPARK INVESTMENT CORPORATION (“PENNANT”), CITIBANK, N.A. (“CITIBANK”), AND THL CREDIT, INC. (“THL” AND TOGETHER WITH BKC, PENNANT PARK, CITIBANK AND THE OTHER PURCHASERS FROM TIME TO TIME PARTIES HERETO (COLLECTIVELY, THE “PURCHASERS”).
          WHEREAS, simultaneously with the transactions contemplated under the Senior Credit Agreement, Issuers wish to sell to Purchasers and Purchasers wish to purchase from Issuers the 13.0% Senior Subordinated Notes Due October 2016 (each, a “Note” and collectively, the “Notes”), in an aggregate principal amount equal to $85,000,000, for the consideration and upon the terms and conditions contained herein; and
          WHEREAS, Holdings and the Subsidiary Guarantors (each, a “Guarantor” and collectively, the “Guarantors”) will derive substantial direct and indirect benefits from the issuance of the Notes hereunder and are willing to guaranty all of the Obligations of Issuers to Purchasers under the Note Documents;
          NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained herein, the parties hereto agree as follows:
ARTICLE 1
DEFINITIONS, INTERPRETATION AND ACCOUNTING TERMS
     Section 1.1 Defined Terms As used in this Agreement, the following terms have the following meanings:
     “Acquired Business” means the assets of Spheris Inc. and its subsidiaries acquired by the Issuers pursuant to the terms of the Acquisition Agreement.
     “Acquisition” means the acquisition by the Issuers of the Acquired Business.
     “Acquisition Agreement” means that certain Stock and Asset Purchase Agreement, dated as of February 2, 2010, by and among Spheris Inc. and certain of its affiliates as sellers and CBay and MedQuist as purchasers.
     “Additional Available Cash” means, on any date, (i) aggregate Excess Cash Flow of Holdings for periods after the Closing Date for which audited financial statements and related Compliance Certificates have been delivered pursuant to Section 6.1(c) and (d) after the Closing Date not required to be paid to the Senior Agent pursuant to Section 2.8(a) of the Senior Credit Agreement plus (ii) aggregate Net Cash Proceeds arising from the issuance or Sale by any Group

7